7investing Lead Advisor Simon Erickson’s Top Stock to Buy in October 2022 is a one-of-a-kind company who is on a global mission.
October 1, 2022
What do Steve Jobs, Jeff Bezos, and Elon Musk have in common? (Cue for a witty answer related to money, ego, or relationships).
The business answer is that they each capitalized on innovative new trends to make fortunes for their investors. Personal computers, the internet, and battery-powered vehicles all needed their visionary leadership in order to go mainstream.
There’s a similar innovative trend brewing in the healthcare industry right now. Personalized medicines allow doctors to use a patient’s own immune system to target very specific strains of cancer. Immunotherapies not only provide superior results, but they also avoid several of the harmful side-effects associated with chemotherapy.
Yet while this is a progressive field full of neat science, it’s still either too expensive or completely inaccessible for the vast majority of the world.
7investing advisor Simon Erickson’s Top Stock for October seeks to change that. It is creating a unique and fast-growing empire that is disrupting the status quo of global drug development.
Every now and then, there are one of a kind companies who are truly unique opportunities for
I’m not talking about companies who are just growing revenues and earnings per share on a steady basis. I’m talking about those with visionary leaders who are on a mission to change the entire world.
These are the companies like Steve Jobs at Apple, who saw the opportunity of putting a supercomputer and information into your hand and into your pocket. I’m talking about Jeff Bezos at Amazon, how he saw the opportunity to use the internet to buy anything and have it delivered to your doorstep. And talking about Elon Musk at Tesla, who saw the opportunity for a lower carbon sustainable energy future.
Every now and then, we get an opportunity to invest into those companies. I’m 7investing lead advisor Simon Erickson, and my top stock idea for October of 2022 is exactly one of these types of companies. It has a truly innovative solution, and it’s unleashing it in a market that badly needs it.
The investing world has been quick to recognize the opportunity for innovation in the tech industry. Whether we’re talking about computing, e-commerce, cloud computing, or artificial intelligence, it feels like there’s no shortage of companies that have gotten in early and harnessed innovative trends to make fortunes for the early investors.
But one industry we talk about a little bit less often is that of healthcare. Keep in mind, this is a multi trillion dollar global market, but it’s also one that’s been slow moving for decades.
All of that’s changing now though, as the significantly reduced costs of genomic sequencing are unlocking a new wave of personalized medicines where doctors can see the genome and the DNA of individual patients. Those new medicines are embraced in many markets, but others are just waking up to their potential.
That’s the opportunity for my company that I’m recommending this month, whose innovative leader sees an opportunity to unleash these in a market that needs the solutions.
To see the name of the company that I’m recommending, as well as all seven of our top stock market opportunities each and every month, click on the link at the end of this video to get started with 7investing today.
We’re here to empower you to invest in your future. We are 7investing!
Already a 7investing member? Log in here.